SCHEMBL2883607

SCHEMBL2883607

CSc1nccc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)n1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 14/20 0.58
CSNK1D P48730 2/20 0.54
JAK3 P52333 1/20 0.54
MAPK13 O15264 2/20 0.48
MAPK12 P53778 2/20 0.48
MAPK11 Q15759 2/20 0.48
PRKD1 Q15139 1/20 0.48
CCNA2 P20248 1/20 0.43
CDK2 P24941 1/20 0.43
CSNK1E P49674 1/20 0.43
CDK5 Q00535 1/20 0.43
CDK5R1 Q15078 1/20 0.43
TGFBR1 P36897 2/20 0.42
TGFBR2 P37173 2/20 0.42
MET P08581 1/20 0.40
KDM4E B2RXH2 1/20 0.38
MAPK1 P28482 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2888593 0.77 MAPK14 (0.72) MAPK14MAPK13MAPK12MAPK11PRKD1
SCHEMBL2286610 0.75 MAPK14 (0.82) MAPK14MAPK13MAPK12MAPK11PRKD1
SCHEMBL21621304 0.74 L3MBTL1 (0.58) MAPK14CSNK1DJAK3MAPK13MAPK12
SCHEMBL284987 0.74 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11PRKD1
SCHEMBL6619193 0.74 MAPK14 (0.53) MAPK14CSNK1DJAK3MAPK13MAPK12
SCHEMBL4974887 0.74 MAPK14 (0.81) MAPK14CSNK1DJAK3MAPK13MAPK12
SCHEMBL6478990 0.72 MAPK14 (0.54) MAPK14CSNK1DJAK3MAPK13MAPK12
SCHEMBL10394696 0.72 MAPK14 (0.63) MAPK14MAPK13MAPK12MAPK11PRKD1
SCHEMBL7670525 0.72 MAPK14 (0.62) MAPK14CSNK1DJAK3MAPK13MAPK12
SCHEMBL6579207 0.72 MAPK14 (0.53) MAPK14CSNK1DJAK3MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084395-B2 4-aza indole derivatives and their use as fungicides SYNGENTA CROP PROTECTION, INC. (US) 2011-12-27 US disclosed
US-20100184598-A1 4-AZA INDOLE DERIVATIVES AND THEIR USE AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-07-22 US disclosed
CN-101784191-A 4-aza indole derivatives and their use as fungicides SYNGENTA PARTICIPATIONS AG 2010-07-21 CN disclosed
EP-2136640-A2 4-AZA INDOLE DERIVATIVES AND THEIR USE AS FUNGICIDES Syngeta Participations AG (CH) 2009-12-30 EP disclosed
WO-2008132434-A2 4-AZA INDOLE DERIVATIVES AND THEIR USE AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184598-A1 4-AZA INDOLE DERIVATIVES AND THEIR USE AS FUNGICIDES IDO1, INMT, AZI2 MAPK14 512/4885CSNK1D 2782/4885JAK3 876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.